Cetera Advisor Networks’s Actinium Pharmaceuticals ATNM Stock Holding History

Cetera Advisor Networks’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-167	Closed	-$2K	–	1343
2020 Q2	$2K	Buy	+167	New	+$1.26K	﹤0.01%	3204
2020 Q1	–	Sell	-4,217	Closed	-$43K	–	1123
2019 Q4	$43K	Sell	4,217 -533	-11%	-$3.68K	﹤0.01%	1230
2019 Q3	$49K	Hold	4,750	–	–	﹤0.01%	1176
2019 Q2	$49K	Hold	4,750	–	–	﹤0.01%	1170
2019 Q1	$58K	Hold	4,750	–	–	﹤0.01%	1129
2018 Q4	$57K	Sell	4,750 -17	-0.4%	-$290	﹤0.01%	1016
2018 Q3	$114K	Buy	4,767 +750	+19%	+$15.3K	﹤0.01%	1098
2018 Q2	$96K	Buy	+4,017	New	+$50.9K	﹤0.01%	822

Other funds holding ATNM

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cetera Advisor Networks's ATNM Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Actinium Pharmaceuticals (ATNM) in Q3 2020, closing a stake of 167 shares — an estimated $2K sold.

Cetera Advisor Networks first reported a position in ATNM in Q2 2018 and held it in 8 quarters. The position peaked at $114K in Q3 2018. 41 funds tracked by Wall St. Rank hold ATNM as of Q3 2020.

Cetera Advisor Networks reported no remaining Actinium Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Cetera Advisor Networks sold 167 Actinium Pharmaceuticals shares in Q3 2020, an estimated $2K.
Cetera Advisor Networks first reported a position in Actinium Pharmaceuticals in Q2 2018 and held it in 8 quarters.
Cetera Advisor Networks's Actinium Pharmaceuticals position peaked at $114K in Q3 2018.
41 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.